CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Efficacy and safety of vedolizumab in ulcerative colitis in patients from Asian countries in the GEMINI 1 study
Choon Jin Ooi, Ida Normiha Hilmi, Hyo-Jong Kim, Umesh Jalihal, Deng-Chyang Wu, Dirk Demuth, Dirk Lindner, Shashi Adsul
Intest Res. 2021;19(1):71-82.   Published online September 4, 2020
DOI: https://doi.org/10.5217/ir.2019.09159

Excel Download

Efficacy and safety of vedolizumab in ulcerative colitis in patients from Asian countries in the GEMINI 1 study
Intestinal Research. 2021;19(1):71-82   Crossref logo
Link1 Link2 Link3

Sa1274 Efficacy and Safety of Vedolizumab With Advancing Age in Patients With Ulcerative Colitis: Results From the GEMINI 1 Study
Gastroenterology. 2015;148(4):S-278-S-279   Crossref logo
Link1 Link2

Efficacy and safety of vedolizumab in Crohn’s disease in patients from Asian countries in the GEMINI 2 study
Intestinal Research. 2021;19(1):83-94   Crossref logo
Link1 Link2 Link3

Sa1271 Efficacy of Vedolizumab With Concomitant Corticosteroid or Immunomodulator Use in Patients With Ulcerative Colitis From GEMINI 1
Gastroenterology. 2015;148(4):S-277-S-278   Crossref logo
Link1 Link2

Mo1882 The Efficacy of Vedolizumab by Disease Activity and Prior Tumor Necrosis Factor α Antagonist Failure in Patients With Ulcerative Colitis or Crohn's Disease: Post Hoc Analyses From the GEMINI 1 and GEMINI 2 Studies
Gastroenterology. 2016;150(4):S804-S805   Crossref logo
Link1 Link2

Histologic Outcomes With Vedolizumab Versus Adalimumab in Ulcerative Colitis: Results From An Efficacy and Safety Study of Vedolizumab Intravenous Compared to Adalimumab Subcutaneous in Participants With Ulcerative Colitis (VARSITY)
Gastroenterology. 2021;161(4):1156-1167.e3   Crossref logo
Link1 Link2

Mo1223 Health-Related Quality of Life in Patients With Ulcerative Colitis After Treatment With Vedolizumab: Results From the Gemini 1 Study
Gastroenterology. 2014;146(5):S-590   Crossref logo
Link1 Link2

Sa1272 Efficacy and Safety of Retreatment With Vedolizumab in Patients With Ulcerative Colitis
Gastroenterology. 2015;148(4):S-278   Crossref logo
Link1 Link2

P427 Efficacy and safety of vedolizumab and adalimumab in Asian adults with moderately to severely active ulcerative colitis: Post-hoc analysis of the VARSITY trial
Journal of Crohn's and Colitis. 2021;15(Supplement_1):S431-S432   Crossref logo
Link1 Link2

P547 Safety and efficacy of vedolizumab in the treatment of patients with moderate to severe Ulcerative Colitis: a systematic review and meta-analysis
Journal of Crohn's and Colitis. 2021;15(Supplement_1):S516-S517   Crossref logo
Link1 Link2